Genital Neoplasms, Female Urogenital Neoplasms
1 clinical trials · Condition
◉ Watch Genital Neoplasms, Female Urogenital Neoplasms
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma (NCT00050440) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-07-01 |
Track Genital Neoplasms, Female Urogenital Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.